• SENSEX 73,768.28
    522.25 (+0.71%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,490.00 1,423.80(%)
  • The Bombay Burmah
    1,203.00 2,050.25(%)
  • Aeroflex
    569.60 613.50(%)
  • NSE
    1,795.00 1,878.00(%)
  • Cholaman.Inv.&Fn
    1,589.95 1,952.00(%)
  • Bajaj Finance
    931.00 1,177.60(%)
  • Reliance Industries
    1,182.00 1,611.20(%)
  • M & M Fin. Serv.
    256.60 253.30(%)
  • Tube Investments
    2,098.60 2,006.00(%)
  • JSW Dulux
    285.65 374.67(%)
  • Birlasoft Ltd
    343.75 473.75(%)
  • Dalmia BharatLtd
    1,403.50 1,464.85(%)
  • Acutaas Chemical
    3,997.20 3,977.00(%)
  • Tonbo Imaging
    1,175.75 1,013.95(%)
  • Apollo Hospitals
    8,239.00 9,326.80(%)
  • Adani Ports
    1,839.80 1,891.80(%)
  • Moneyview
    51.92 65.43(%)
  • DLF
    674.90 786.40(%)
  • Indian Hotels Co
    815.50 815.25(%)
  • Coromandel Inter
    1,728.85 2,496.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zim Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4284.0
  • ISIN : INE518E01015
141.26 7 (5.56%)
  • As on 29 Oct 2026 (EOD)

  • Today’s Low

    130.01

  • Today’s High

    143.29

  • Open

    130.35

  • Perv Close

    133.82

  • 52W Low

    59.31

  • 52W High

    159.81

Key Indicators

  • P/E(TTM)

    202.57

  • Mar.Cap (₹Cr.)

    757.98

  • Div & Yield %

    0.00

  • Book Value(₹)

    52.94

  • Debt-Equity Ratio

    5.56

  • AGM Date

    28-Oct-2026

  • EPS

    0.70

  • P/E Ratio

    202.57

Financials Ratios

  • Debt-Equity Ratio

    0.40

  • Mar.Cap (₹Cr.)

    757.98

  • RONW (%)

    7.86

  • ROCE (%)

    9.97

Score Board

  • Equity (₹ in Cr.)

    53.66

  • BV (₹)

    52.90

  • Sales( ₹ in Cr.)

    370.48

  • NP (in Cr.)

    4.41

  • NP Var(%)

    -62.0

  • Div%

    0.0

  • CPS (₹)

    4.40

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    760.88

  • 52 Week High

    159.81

  • 52 Week Low

    59.31

  • Price BSE

    142.0

  • Price NSE

    141.00

  • Market Capital( in Cr.)

    760.88

  • P/C Ratio

    32.00

  • P/E Ratio

    172.80

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 370.48 375.64 365.47 396.53 329.49 303.63
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 370.48 375.64 365.47 396.53 329.49 303.63
Other Income 11.39 5.62 4.69 6.43 4.51 2.45
Stock Adjustments 6.14 -1.27 14.05 -16.46 9.67 1.11
Total Income 388.01 379.99 384.21 386.50 343.67 307.19
EXPENDITURE :            
Raw Materials 170.66 166.58 185.49 182.37 170.02 159.74
Power and Fuel Cost 18.17 17.39 13.47 11.09 9.14 7.04
Employee Cost 60.10 56.41 50.81 46.47 38.63 34.48
Other Manufacturing Expenses 38.46 32.14 31.97 27.30 23.76 19.02
Selling and Administration Expenses 54.47 52.04 51.66 55.69 54.44 43.70
Miscellaneous Expenses 5.19 6.54 6.03 5.95 5.24 9.12
Employee Benefit Expenses 60.10 56.41 50.81 46.47 38.63 34.48
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 347.04 331.10 339.42 328.87 301.23 273.11
Operating Profit 40.97 48.89 44.79 57.63 42.44 34.08
Interest 13.20 11.39 6.92 5.58 8.31 10.89
Gross Profit 27.77 37.50 37.87 52.05 34.13 23.19
Depreciation 19.37 19.89 14.83 16.13 14.84 14.61
Profit Before Tax 8.40 17.61 23.04 35.92 19.29 8.58
Current Tax 3.28 4.45 0.83 6.28 3.40 0.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.84 1.42 5.45 4.63 2.88 2.95
Reported Net Profit 5.97 11.74 16.76 25.01 13.01 5.62
Extraordinary Items 1.56 0.08 -0.01 0.00 0.00 -3.39
Adjusted Net Profit 4.41 11.66 16.77 25.01 13.01 9.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 163.94 152.73 136.36 111.81 98.76 93.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.10 0.54 0.38 0.46 -0.05 0.39
P & L Balance carried down 169.81 163.94 152.73 136.36 111.81 98.76
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.11 2.41 3.44 5.13 8.01 3.46
Earnings Per Share(Adj)-Unit Curr 1.11 2.41 3.44 5.13 2.67 1.15
Book Value 53.07 49.90 47.60 39.85 104.73 96.69
Book Value(Adj)-Unit Curr 53.07 49.90 47.60 39.85 34.91 32.23

Shareholding Pattern

  • Promoter Group

    30.30%

  • Public Share Holding

    69.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 16,258,500 30.30 16,258,500 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,258,500 30.30 16,258,500 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 91,037 0.17 91,037 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 631,193 1.18 631,193 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,000 0.01 5,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 727,230 1.36 727,230 5
2] Non Institution
Bodies Corporate 9,600,019 17.89 9,552,619 113
Clearing Members 14,947 0.03 14,947 7
Directors of their Relatives 706,737 1.32 706,537 9
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,411,000 4.49 965,392 260
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 354,941 0.66 354,941 244
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,437,682 17.59 9,392,562 76
Individuals holding nominal share capital up to Rs. 1 lakh 7,215,087 13.45 6,372,287 12,322
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,945,480 3.63 1,945,480 3
Sub Total 36,672,758 68.34 34,291,630 13,045
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 53,658,488 100.00 51,277,360 13,057

Company Background

Zim Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zim Laboratories Ltd
  • BSE Code : 4284.0
  • ISIN : INE518E01015

  • Incorporation Year

    1984

  • Registered Office

    Sadoday Gyan (Gr Floor)
    Opp NADT Nelson Square, Nagpur,
    Maharashtra-440013

  • Telephone

    91-712-2588070

  • FAX

  • Chairman

    Anwar Daud

  • Managing Director

  • Company Secretary

    Piyush Nikhade

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Zim Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zim Laboratories 141.80 381.87 370.48 202.57 4.92
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77